Investment accounts

Authorised and regulated by the UK’s FCA to provide investment accounts, we are bound by CASS rules to segregate and protect client assets.

August 2019 investment update

With US vs China and UK vs the EU we anticipate bouts of elevated volatility in H2 2019 – which will require nimble movement in and out of equity markets to avoid losses. Our August monthly investment update is now available to download and view online.

The end of the grid

The entrenched, centralised nature of our electricity supply is being disrupted, largely by community energy projects. But what does this mean for the sector?

Dolfin Quarterly magazine now available online

For the first time since we began publishing it in 2017, our latest DQ magazine is available for download. If you haven’t yet picked up your printed copy at our offices, please help yourself to the Summer 2019 issue as a PDF below.

Healthcare and technology: Bringing innovation to life

A panel discussion bringing together scientists, investors, and entrepreneurs to explore investing in innovative health technologies.

24 April 2019, 16:30 - 20:00 / 50 BERKELEY STREET, W1J 8HA

From a lab trial to a healthcare breakthrough: what does it take for innovative technologies to enter the market and make a life-changing health solution available to millions of patients? How to accelerate the discovery and implementation of health innovation and turn cutting-edge scientific research into a profitable business? And how can investors take advantage of opportunities in this sector at an early stage, while enabling the latest proven technologies transform health outcomes and make a real positive impact on the society?

Dolfin and Aescuvest present a panel discussion bringing together leading European scientists with healthcare investors and entrepreneurs, to explore technologies and processes that drive better outcomes, for patients and investors alike.

Speakers

  • Benno Groosman – Serial entrepreneur, CEO Surge-on Medical, CFO VirtualMedSchool, start-up ecosystem consultant
  • Prof Roman Hovorka – Professor of Metabolic Technology, University of Cambridge, Director of research group developing and clinically testing the artificial pancreas
  • Dr Kurt Höller, Director of Business Creation at EIT Health
  • Dr Patrick Pfeffer – CEO and founder of Aescuvest
  • Carolyn Porter,  Chief Business Officer, OxStem
  • Dr Andreas Schmidt – CEO of Proteona, a venture capital backed
    biomedical company combining both genomic and proteomic data for single cell analysis

Who should attend

Dolfin clients, including Private and Institutional investors, External Asset Managers; VCs, who are interested to identify investment opportunities in the Healthcare sector as well as C-Suite executives from the biotech, health care and life sciences industries.

Agenda

16:30Doors open and registration
17:00 Welcome remarks, Dolfin
17:05 Keynote speech, Dr Kurt Höller, Director of Business Creation at EIT Health
17:15Panel discussion and Q&A
18:15Closing remarks, Dr Patrick Pfeffer, CEO and founder of Aescuvest
18:30Reception

Investment accounts

Dolfin’s investment accounts safeguard securities and cash, while ensuring you or your clients can take full advantage of multi-asset, multi-currency, and multi-strategy investments.

Learn more

About us

Founded as a London-based wealth boutique in 2013, today we’re a diversified financial services firm with an international presence and our own bespoke technology platform.

Learn more